The dynamic pore systems and high surface areas of flexible metal–organic framework materials make them excellent candidates to be used in different kinds of adsorption processes. However, the adsorption and desorption behaviors of therapeutic drugs on metal–organic frameworks in solution are not fully developed. Here, we systematically investigated the adsorption and desorption behaviors of a typical therapeutic drug, verapamil, over several Zr-based metal–organic frameworks [e.g., Zr-FUM, UiO-66(Zr), UiO-66(Zr)-NH₂ and UiO-66(Zr)-2COOH] as well as ZrO₂ in an acetonitrile solution by using paper spray mass spectrometry. In contrast to other materials, UiO-66(Zr)-2COOH demonstrated a superior adsorption performance to verapamil due to their strong acid-base and/or hydrogen-bond interactions, and the adsorption process fitted well with the pseudo-second-order kinetic model. As verapamil-adsorbed materials were used for desorption experiments, ZrO₂ demonstrated the most favorable desorption performance, whereas UiO-66(Zr)-2COOH yielded the poorest desorption capability. These Zr-based materials had also been coated at the surface with filter papers for the analysis of various drugs and proteins in the process of paper spray mass spectrometry. The results demonstrated that among the studied materials, ZrO₂-coated paper gave the most favorable desorption performance as a pure drug solution, whereas the paper from UiO-66(Zr) demonstrated the optimal capability in the analyses of therapeutic drugs in a complex matrix (e.g., blood) and a protein (e.g., myoglobin). Full article

Taking net power output as the optimization objective, the exergy loss distribution of the subcritical Organic Rankine Cycle (ORC) system by using R245fa as the working fluid was calculated under the optimal conditions. The influences of heat source temperature, the evaporator pinch point temperature difference, the expander isentropic efficiency and the cooling water temperature rise on the exergy loss distribution of subcritical ORC system are comprehensively discussed. It is found that there exists a critical value of expander isentropic efficiency and cooling water temperature rise, respectively, under certain conditions. The magnitude of critical value will affect the relative distribution of exergy loss in the expander, the evaporator and the condenser. The research results will help to better understand the characteristics of the exergy loss distribution in an ORC system. Full article

Ru is considered as an effective active species for N₂O decomposition; however, there is disagreement about which ruthenium species is key for catalytic activity. In order to understand the role of Ru species in N₂O decomposition, Ru/Al₂O₃ (Ru/Al₂O₃-H₂, Ru/Al₂O₃-NaBH₄, Ru/Al₂O₃-air) catalysts with different ratios of metallic Ru were prepared and evaluated for their catalytic activities. Various characterizations, especially in situ diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS), were applied to investigate the relationship between activity and different Ru species. The results indicate that the N₂O conversion displayed a linear relationship with the amount of metallic Ru. The DRIFTS results of adsorption for N₂O show that metallic Ru was the active site. The catalytic processes are put forward based on metallic Ru species. The deactivation with increasing times used is due to the decrease in the amount of metallic Ru and agglomerates of Ru particles on the surface of catalysts. Full article

Nanoparticle drug delivery (NDDS) is a novel system in which the drugs are delivered to the site of action by small particles in the nanometer range. Natural or synthetic polymers are used as vectors in NDDS, as they provide targeted, sustained release and biodegradability. Here, we used the chitosan and hepatoma cell-specific binding molecule, glycyrrhetinic acid (GA), to synthesize glycyrrhetinic acid-modified chitosan (GA-CTS). The synthetic product was confirmed by Fourier transformed infrared spectroscopy (FT-IR) and ¹H-nuclear magnetic resonance (¹H-NMR). By combining GA-CTS and 5-FU (5-fluorouracil), we obtained a GA-CTS/5-FU nanoparticle, with a particle size of 217.2 nm, a drug loading of 1.56% and a polydispersity index of 0.003. The GA-CTS/5-FU nanoparticle provided a sustained release system comprising three distinct phases of quick, steady and slow release. We demonstrated that the nanoparticle accumulated in the liver. In vitro data indicated that it had a dose- and time-dependent anti-cancer effect. The effective drug exposure time against hepatic cancer cells was increased in comparison with that observed with 5-FU. Additionally, GA-CTS/5-FU significantly inhibited the growth of drug-resistant hepatoma, which may compensate for the drug-resistance of 5-FU. In vivo studies on an orthotropic liver cancer mouse model demonstrated that GA-CTS/5-FU significantly inhibited tumor growth, resulting in increased survival time. Full article